Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Selected top psychiatric drugs' U.S. revenue in 2016 (in million U.S. dollars)

Exclusive Premium Statistic

Top psychiatric drugs in the United States by sales 2016 This statistic displays the some of the best-selling psychiatric drugs in the United States during 2016. During this period, Lyrica generated a revenue of some 4.4 billion U.S. dollars. Lyrica is an anticonvulsant drug marketed by Pfizer. In the United States, it is most commonly used for neuropathic pain.
Show more
Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

© Statista 2018

Download Settings Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Description Source More information
This statistic displays the some of the best-selling psychiatric drugs in the United States during 2016. During this period, Lyrica generated a revenue of some 4.4 billion U.S. dollars. Lyrica is an anticonvulsant drug marketed by Pfizer. In the United States, it is most commonly used for neuropathic pain.
Show more
Release date
April 2017
Region
United States
Survey time period
2016
Supplementary notes
This statistic was assembled from several sources.
* Includes sales from Bristol-Myers Squibb and Otsuka (Abilify+Abilify Maintena).

Statista Accounts: Access All Statistics. Starting from $588 / Year

Leading companies trust Statista:

Related Studies: Available to Download in PDF or PPTX Format

Pharmaceutical brands: Cymbalta (Eli Lilly)

All Information
in one Presentation

Pharmaceutical brands: Cymbalta (Eli Lilly)

Everything On "Pharmaceutical brands: Cymbalta (Eli Lilly)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Top pharmaceutical drugs"

  • Global overview
  • Select therapy classes - global
The most important statistics
  • U.S. overview
The most important statistics
  • Select therapy classes - U.S.
Statista for your company

Saves time and money: instant access to this and 1 million more statistics.
Access to dossiers, industry reports and many other studies.

Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.